Top Midday Stories: JPMorgan Shares Rise Despite Q3 Miss; J&J EPS Guidance Undershoots Estimates, Shares Fall

MT Newswires Live
4 hours ago

All three major US stock indexes were down in late-morning trading Tuesday, as the big banks kicked off earning season earlier in the morning.

In company news, JPMorgan Chase (JPM) reported Q3 earnings Tuesday of $5.57 per diluted share, up from $5.07 a year earlier but below the FactSet consensus analyst estimate of $5.93. Third-quarter net revenue was $50.17 billion, up from $46.43 billion a year ago but below the FactSet consensus of $51.23 billion. For Q4, JPMorgan expects net interest income of around $28 billion, above the FactSet consensus of $27.42 billion. For 2026, the bank expects net interest income of $106.2 billion, up from its previous guidance of $105.5 billion and above the FactSet consensus of $105.36 billion. JPMorgan shares were up 1.0% around midday.

Johnson & Johnson (JNJ) reported fiscal Q3 adjusted EPS Tuesday of $2.59, down from $2.80 a year earlier but above the FactSet consensus of $2.52. Reported Q3 sales were $25.40 billion, up from $23.99 billion a year ago and above the FactSet consensus of $25.38 billion. For fiscal 2026, the company expects adjusted EPS of $11.05 to $11.15, up from its previous guidance of $10.96 to $11.11 but below the FactSet consensus of $11.19. Fiscal 2026 sales are expected to be between $101.0 billion and $101.4 billion, revised from its previous guidance of $100.8 billion to $101.4 billion and compared with the FactSet consensus of $101.33 billion. Additionally, Chief Executive Joe Wolk told CNBC in an interview the company is targeting mid-2027 for the spinoff of its orthopedics unit DePuy Synthes. Johnson & Johnson shares were down 5.6%.

UnitedHealth Group (UNH) reported Q3 adjusted EPS of $4.69, up from $2.92 a year earlier and above the FactSet consensus of $4.14. Third-quarter revenue was $112.69 billion, down from $113.16 billion a year ago but above the FactSet consensus of $111.31 billion. For 2026, the company expects adjusted EPS of at least $20.50, up from its prior guidance of $19.50 to $20 and above the FactSet consensus of $19.80. UnitedHealth shares were down 0.6%.

Goldman Sachs (GS) reported Q3 EPS Tuesday of $17.01, up from $12.25 a year earlier and above the FactSet consensus of $12.86. Net revenue was $18.68 billion, up from $15.18 billion a year ago and above the FactSet consensus of $16.83 billion. Goldman shares were up 0.5%.

Wells Fargo (WFC) reported Q3 earnings Tuesday of $1.87 per diluted share, up from $1.66 a year earlier and above the FactSet consensus of $1.85. Third-quarter revenue was $21.87 billion, up from $21.44 billion a year ago but below the FactSet consensus of $22.31 billion. For Q4, the company expects net interest income of about $13 billion, above the FactSet consensus of $12.86 billion. Wells Fargo shares were down 1.2%.

Citigroup (C) reported Q3 EPS Tuesday of $2.85, up from $1.86 a year earlier and above the FactSet consensus of $2.65. Third-quarter revenue was $23.85 billion, up from $22.08 billion a year ago and above the FactSet consensus of $23.72 billion. Citigroup shares were down 2.3%.

Bumble (BMBL) said Tuesday it has entered into a definitive agreement to be acquired by Ithaca Holdings in an all-cash deal valuing the dating app at $1.3 billion. Under the terms of the agreement, Bumble shareholders will receive $6.05 per share of Class A common stock, representing a premium of about 138% to the unaffected closing price of its shares on Oct. 9. Bumble shares were up 56.2%.

Anthropic plans to reveal its Q3 financials for the first time on Wednesday at a meeting with potential investors, as it prepares for its initial public offering, CNBC reported Tuesday, citing two people familiar with the matter.

Price: 338.04, Change: +3.74, Percent Change: +1.12

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10